Related Experiment Video
Updated: Jun 18, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Economic evaluation of a routine rotavirus vaccination programme in Indonesia
Siswanto Agus Wilopo1, Paul Kilgore, Soewarta Kosen
1Centre of Reproductive Health, Department of Public Health, Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia. sawilopo@yahoo.com
Abstract:
An economic evaluation was undertaken to assess the potential for introducing rotavirus vaccine into Indonesia's National Immunization Program. For a projected birth cohort of 4.2 million children was followed until 5 years of age, a routine rotavirus vaccination programme could potentially avert 488,547 cases of diarrhoea treated in outpatient hospital facilities, 176,375 hospitalizations, and 8148 deaths. Assuming a cost of US$ 14 per vaccine course, the incremental cost-effectiveness ratio would equal US$ 120.46 per disability adjusted life years averted, making routine vaccination highly cost-effective given Indonesia's Gross National Income per capita of US$ 1560. At a cost per vaccine course of US$ 3.79 (societal perspective) or US$ 2.70 (health-care system perspective), routine rotavirus vaccination could be potentially cost-saving in Indonesia.
Related Concept Videos
Vaccinations
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Poliomyelitis
Smallpox
Vaccine Production
Respiratory Syncytial Virus Disease
